Načítá se...
Amantadine Therapy for Chronic Hepatitis C: A Randomized Double-blind Placebo-controlled Trial
OBJECTIVE: Although treatment of hepatitis C has improved, up to 50% do not respond to standard therapy with interferon regimes or cannot tolerate the treatment due to side effects. The purpose of the present investigation was to evaluate the safety and effectiveness of the antiviral drug amantadine...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Blackwell Science Inc
2004
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1492374/ https://ncbi.nlm.nih.gov/pubmed/15209605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1525-1497.2004.30057.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|